OBJECTIVES: To describe the University of Tennessee PharmD/PhD program and assess the prevalence and characteristics of PharmD/PhD programs in the United States. METHODS: Survey instruments were mailed in May 2004 to UT dual-degree program participants and deans of US colleges and schools of pharmacy. RESULTS: University of Tennessee PharmD/PhD students completed more than 30 hours of graduate credit before obtaining their PharmD and 72.2% agreed or strongly agreed that the program met their professional goals. More than 40% of US pharmacy colleges and schools have or plan to have PharmD/PhD programs. A wide variation exists in the level of integration, PhD concentrations offered, entrance requirements, and student benefits. Most schools with PharmD/PhD programs had few students enrolled in the program, but attrition rates were low (<20%) for 69% of the schools. CONCLUSIONS: Dual-degree programs attract and retain pharmacy students in research programs and 47.6% of graduates entered academia and industry.
OBJECTIVES: To describe the University of Tennessee PharmD/PhD program and assess the prevalence and characteristics of PharmD/PhD programs in the United States. METHODS: Survey instruments were mailed in May 2004 to UT dual-degree program participants and deans of US colleges and schools of pharmacy. RESULTS: University of Tennessee PharmD/PhD students completed more than 30 hours of graduate credit before obtaining their PharmD and 72.2% agreed or strongly agreed that the program met their professional goals. More than 40% of US pharmacy colleges and schools have or plan to have PharmD/PhD programs. A wide variation exists in the level of integration, PhD concentrations offered, entrance requirements, and student benefits. Most schools with PharmD/PhD programs had few students enrolled in the program, but attrition rates were low (<20%) for 69% of the schools. CONCLUSIONS: Dual-degree programs attract and retain pharmacy students in research programs and 47.6% of graduates entered academia and industry.
Authors: Michael A Tortorici; Susan J Skledar; Michael A Zemaitis; Robert J Weber; Randall B Smith; Patricia D Kroboth; Samuel M Poloyac Journal: Am J Pharm Educ Date: 2007-04-15 Impact factor: 2.047
Authors: Justine S Gortney; Sheila Seed; Nancy Borja-Hart; Veronica Young; Lisa J Woodard; Dolores Nobles-Knight; David M Scott; James D Nash Journal: Am J Pharm Educ Date: 2013-08-12 Impact factor: 2.047
Authors: Samuel M Poloyac; Kerry M Empey; Lisa C Rohan; Susan J Skledar; Philip E Empey; Thomas D Nolin; Robert R Bies; Robert B Gibbs; Maggie Folan; Patricia D Kroboth Journal: Am J Pharm Educ Date: 2011-03-10 Impact factor: 2.047